DCM
Universal Safety Products, Inc.
There isn't enough reported data to score DCM yet.
RKLB
Rocket Lab USA, Inc.
RKLB lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.
DCM Fundamentals
| Metric | Status |
|---|---|
| Weak | |
| Weak | |
| Weak | |
| Weak |
DCM's revenue, profitability, cash flow and balance sheet are all currently weak.
RKLB Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
RKLB's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
DCM PE Valuation
DCM has no meaningful PE right now: it lost money over the past year.
RKLB PE Valuation
RKLB has no meaningful PE right now: it lost money over the past year.
DCM Forward outlook
There aren't enough analyst estimates for DCM to show an outlook.
RKLB Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect RKLB's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
DCM Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$2.05 | -272% |
| Q1 2026 | -$1.04 | -573% |
| Q4 2025 | -$0.08 | +$0.46 |
| Q3 2025 | $0.51 | +$0.61 |
| Q2 2025 | $1.19 | +$1.62 |
| Q1 2025 | $0.22 | +$0.39 |
| Q4 2024 | -$0.54 | -460% |
| Q3 2024 | -$0.10 | -138% |
DCM has swung to a loss: it lost $2.05 per share over the past year, after a profit the year before.
RKLB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.36 | +$0.03 |
| Q2 2026 | -$0.27 | +$0.19 |
| Q1 2026 | -$0.32 | +$0.09 |
| Q4 2025 | -$0.37 | +$0.01 |
| Q3 2025 | -$0.39 | -$0.02 |
| Q2 2025 | -$0.46 | -$0.11 |
| Q1 2025 | -$0.41 | -$0.04 |
| Q4 2024 | -$0.38 | $0.00 |
RKLB is still losing money, but less than at its worst: $0.36 per share over the past year, against $0.46 at its worst in mid-2025.
DCM Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $109.6K | -97% |
| Q1 2026 | $240.4K | -96% |
| Q4 2025 | $22.5K | -100% |
| Q3 2025 | $760K | -89% |
| Q2 2025 | $3.8M | -17% |
| Q1 2025 | $6.2M | +29% |
| Q4 2024 | $5.5M | +19% |
| Q3 2024 | $7.2M | +94% |
DCM's revenue has slid since its 2024 peak: $109,559 last quarter, down 97% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -673% | -659 points |
| Q1 2026 | -419% | -435 points |
| Q4 2025 | -9700% | -9685 points |
| Q3 2025 | -122% | -132 points |
| Q2 2025 | -14% | -5.3 points |
| Q1 2025 | 16% | +25 points |
| Q4 2024 | -16% | -18 points |
| Q3 2024 | 9.4% | +14 points |
DCM's operating margin was −673% last quarter, down 659 points from the same quarter a year ago, near the bottom of its range since 2019.
RKLB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $267.8M | +73% |
| Q2 2026 | $234.1M | +62% |
| Q1 2026 | $200.3M | +63% |
| Q4 2025 | $179.7M | +36% |
| Q3 2025 | $155.1M | +48% |
| Q2 2025 | $144.5M | +36% |
| Q1 2025 | $122.6M | +32% |
| Q4 2024 | $132.4M | +121% |
RKLB has the edge over DCM on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -30% | +8.5 points |
| Q2 2026 | -25% | +17 points |
| Q1 2026 | -28% | +20 points |
| Q4 2025 | -28% | +11 points |
| Q3 2025 | -38% | +12 points |
| Q2 2025 | -41% | -0.5 points |
| Q1 2025 | -48% | -1.9 points |
| Q4 2024 | -39% | +41 points |
RKLB has the edge over DCM on profitability, with a higher operating margin.
DCM Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$733.2K | -127% |
| Q1 2026 | -$811.4K | -$499.8K |
| Q4 2025 | -$2.6M | -202% |
| Q3 2025 | $1.2M | +$3.3M |
| Q2 2025 | $2.8M | +$4M |
| Q1 2025 | -$311.6K | -182% |
| Q4 2024 | $2.5M | +$3M |
| Q3 2024 | -$2.1M | -541% |
DCM's free cash flow was −$3M over the past year, against $3M the year before.
RKLB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$23.9M | +$45.5M |
| Q2 2026 | -$110.1M | -$54.8M |
| Q1 2026 | -$77.4M | +$5.5M |
| Q4 2025 | -$114.2M | -$90.2M |
| Q3 2025 | -$69.4M | -$27.5M |
| Q2 2025 | -$55.3M | -$26.9M |
| Q1 2025 | -$82.9M | -$61.1M |
| Q4 2024 | -$23.9M | +$28.7M |
RKLB has burned cash in almost every quarter: −$326M over the past year, against −$232M the year before.
DCM Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +27% | +624K shares |
| 1 year | +27% | +624K shares |
| 3 years | +27% | +624K shares |
| 5 years | +27% | +624K shares |
| Available history | +27% | +624K shares |
DCM has 3M diluted shares, up 27% from a year ago.
RKLB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.6% | +22.6M shares |
| 1 year | +23% | +124M shares |
| 3 years | +35% | +168M shares |
| 5 years | +46% | +204M shares |
RKLB has the edge over DCM on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2020 | — |
| Q2 2020 | — |
| Q1 2020 | — |
DCM Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2025 | 4.3x | High |
| Q4 2023 | 4.3x | High |
| Q3 2023 | 1.9x | Healthy |
| Q2 2023 | 2.0x | Healthy |
| Q1 2023 | 1.3x | Healthy |
| Q4 2022 | -0.2x | Net Cash |
| Q3 2022 | -0.5x | Net Cash |
| Q2 2022 | -26.9x | Net Cash |
DCM's net debt is about 4.3 years of its operating earnings (EBITDA), up from 1.3 years a year ago.
RKLB Net Leverage
RKLB's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
DCM Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.5 | Neutral |
| Stochastic | 5.7 | Oversold |
DCM's weekly RSI is 37 (neutral) and its Stochastic is 6 (oversold).
RKLB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.8 | Neutral |
| Stochastic | 27.6 | Neutral |
RKLB's weekly RSI is 47 (neutral) and its Stochastic is 28 (neutral).
DCM PE vs Industrials Sector
| Metric | DCM | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 24x | — |
DCM has no meaningful PE right now: it lost money over the past year.
RKLB PE vs Industrials Sector
RKLB has no meaningful PE right now: it lost money over the past year.
DCM Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.16 | 27% below |
| 20 week MA | $4.32 | 30% below |
| 50 week MA | $5.02 | 40% below |
| 100 week MA | $4.10 | 26% below |
| 200 week MA | $3.05 | 0.7% below |
DCM is in a downtrend: it's below all five of its weekly moving averages, and 0.7% below its 200-week average.
RKLB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $61.4 | 4.3% above |
| 20 week MA | $68.1 | 5.9% below |
| 50 week MA | $77.6 | 17% below |
| 100 week MA | $56.5 | 13% above |
| 200 week MA | $31.4 | 104% above |
RKLB has the edge over DCM on trend strength, trading above more of its moving averages.
DCM Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $0.61 | $2.91 | +377% |
| 2021 | $2.91 | $3.64 | +25% |
| 2022 | $3.64 | $2.10 | -42% |
| 2023 | $2.10 | $1.66 | -21% |
| 2024 | $1.66 | $2.31 | +39% |
| 2025 | $2.31 | $5.00 | +116% |
| 2026 YTD | $5.00 | $3.03 | -39% |
DCM's yearly returns have swung widely, from +377% in 2020 to −42% in 2022. It's down 39% so far in 2026.
RKLB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.82 | $10.3 | +4.9% |
| 2021 | $10.3 | $12.0 | +17% |
| 2022 | $12.0 | $3.77 | -69% |
| 2023 | $3.77 | $5.53 | +47% |
| 2024 | $5.53 | $27.2 | +392% |
| 2025 | $27.2 | $70.7 | +160% |
| 2026 YTD | $70.7 | $64.1 | -9.3% |
RKLB has the edge over DCM on returns for 2026, with the stronger performance.